As of Mar 31
| -0.68 / -4.90%|
The 5 analysts offering 12-month price forecasts for Cytosorbents Corp have a median target of 18.75, with a high estimate of 30.00 and a low estimate of 12.00. The median estimate represents a +42.15% increase from the last price of 13.19.
The current consensus among 5 polled investment analysts is to Buy stock in Cytosorbents Corp. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.